The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.

Clinical trial NCT07483502 · RECRUITING

Trial details

NCT number: NCT07483502
Sponsor: Hull University Teaching Hospitals NHS Trust
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cardiovascular Diseases (CVD)Cardiovascular Surgery

Start date: 2026-04-09
Primary completion: 2026-10-28
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.